Vivo Opportunity Fund Holdings, L.P.
Director at UNCY; 10% owner at SOLENO THERAPEUTICS INC; Director at TERN
- Sold, on record
- $176M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Mar 28, 2025
- Form 144 notices
- 3
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- UNCYUnicycive Therapeutics, Inc.Director
- SOLENO THERAPEUTICS INC10% owner
- TERNTerns Pharmaceuticals, Inc.Director
Sales by reason
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice TERNNoticeApr 1, 2024 2024
Filed to sell 221,095 shares ($1.6M)
Vivo Opportunity Fund Holdings, L.P., Director
10b5-1 planFirst sale on recordFiling
- 2 Form 144 notice TERNNoticeApr 3, 2024 +2 days
Filed to sell 136,258 shares ($818k)
Vivo Opportunity Fund Holdings, L.P., Director
10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale SOLENO THERAPEUTICS INCNo planApr 30, 2024 +27 days
Sold 1.1M shares at $46.95 ($51.7M)
Vivo Opportunity Fund Holdings, L.P., 10% owner
No 10b5-1 planSold 13.1% of holdings ($395M position)7.3M shares leftFirst sale on recordFiling
- 4 Form 4 sale SOLENO THERAPEUTICS INCUnusualMar 28, 2025 +332 days
Sold 1.8M shares at $67.87 ($124M)
Vivo Opportunity Fund Holdings, L.P., 10% owner
No 10b5-1 planSold 29.1% of holdings ($427M position)4.5M shares leftFiling
- 5 Form 144 notice UNCYNoticeJul 1, 2026 +460 days
Filed to sell 1.8M shares ($9.5M)
Vivo Opportunity Fund Holdings, L.P., Director
No 10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 1, 2026 | UNCY | Director | Form 144 notice | 1.8M | $9.5M | Notice | SEC | |
| Mar 28, 2025 | Mar 28, 2025 | SOLENO THERAPEUTICS INC | 10% owner | Form 4 sale | 1.8M | $124M | 29.1% | Unusual | SEC |
| Apr 30, 2024 | May 1, 2024 | SOLENO THERAPEUTICS INC | 10% owner | Form 4 sale | 1.1M | $51.7M | 13.1% | No plan | SEC |
| Apr 3, 2024 | Apr 3, 2024 | TERN | Director | Form 144 notice | 136,258 | $818k | Notice | SEC | |
| Apr 1, 2024 | Apr 1, 2024 | TERN | Director | Form 144 notice | 221,095 | $1.6M | Notice | SEC |